Cerenion named a Rising Star by the Nordic Life Science Magazine
The latest issue of the Nordic Life Science Magazine has included five Nordic companies, one from each Nordic country, on the list of up-and-coming life science start-ups. Cerenion Oy holds the pole position among the companies chosen as number 1.
‘It is a deep honor for us to be recognized in this way, and to represent Finland in this stellar group of Nordic life science start-ups,’ said Dr. Timo Koskela, CEO of Cerenion.
Other selected companies: Coripharma from Iceland, PCI Biotech from Norway, Particle3D from Denmark and Cellink from Sweden.
Oulu-based Cerenion has deloped the world’s first practical method for measuring the brain function of intensive care patients. The company has a portfolio of international patents pending, a growing body of clinical evidence and eight employees at two locations in Finland.